Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 20,779,789
- Share change
- -2,110,169
- Total reported value
- $113,038,430
- Price per share
- $5.44
- Number of holders
- 35
- Value change
- -$10,373,847
- Number of buys
- 15
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 221015100:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.4%
|
6,767,584
|
$20,370,000 | — | 30 Sep 2019 | |
| ADAMS STREET PARTNERS LLC |
13F
|
Company |
3.6%
|
3,275,616
|
$9,860,000 | — | 30 Sep 2019 | |
| BVF INC/IL |
13F
|
Company |
3.3%
|
3,047,155
|
$9,172,000 | — | 30 Sep 2019 | |
| Novo Holdings A/S |
13F
|
Company |
3.2%
|
2,927,560
|
$8,812,000 | — | 30 Sep 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
1,596,569
|
$4,806,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
952,197
|
$2,866,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.94%
|
851,778
|
$2,564,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.63%
|
574,091
|
$1,728,000 | — | 30 Sep 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.52%
|
474,634
|
$1,429,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.47%
|
426,656
|
$1,284,000 | — | 30 Sep 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.44%
|
400,000
|
$1,204,000 | — | 30 Sep 2019 | |
| CHI Advisors LLC |
13F
|
Company |
0.43%
|
390,307
|
$1,175,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.37%
|
334,096
|
$1,006,000 | — | 30 Sep 2019 | |
| Hikari Power Ltd |
13F
|
Company |
0.14%
|
130,000
|
$391,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
129,357
|
$389,000 | — | 30 Sep 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.14%
|
123,709
|
$372,000 | — | 30 Sep 2019 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.08%
|
74,725
|
$225,000 | — | 30 Sep 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.07%
|
64,048
|
$193,000 | — | 30 Sep 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
59,883
|
$180,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
47,427
|
$143,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
45,371
|
$136,000 | — | 30 Sep 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
43,578
|
$131,000 | — | 30 Sep 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.05%
|
43,017
|
$129,000 | — | 30 Sep 2019 | |
| Puissance Capital Management LP |
13F
|
Company |
0.04%
|
38,010
|
$114,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
27,246
|
$82,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
21,299
|
$64,000 | — | 30 Sep 2019 | |
| RAYMOND JAMES TRUST N.A. |
13F
|
Company |
0.01%
|
13,158
|
$40,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
3,538
|
$11,000 | — | 30 Sep 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
2,222
|
$7,000 | — | 30 Sep 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,147
|
$6,000 | — | 30 Sep 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,806
|
$5,436 | — | 30 Sep 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,564
|
$5,000 | — | 30 Sep 2019 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Sep 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
337
|
$1,000 | — | 30 Sep 2019 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q4 2019
As of 31 Dec 2019,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,779,789 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Novo Holdings A/S, BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, EcoR1 Capital, LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
34
Q4 2019 holders
35
Holder diff
1
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.